Back to News
Market Impact: 0.05

Texas Cardiac Arrhythmia Institute в медицинском центре St. David's Medical Center впервые в США принял участие в испытаниях инновационной системы картирования и абляции импульсным полем

Source: PR Newswire

Healthcare & BiotechTechnology & Innovation

Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center in Austin, Texas, announced it became the first institution in the U.S. to participate in a clinical trial evaluating the safety and efficacy of a new system for arrhythmia treatment. The release is informational (trial participation only) with no reported efficacy results, financial terms, or guidance, implying limited near-term market impact.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.05

More News

From AllMind Research

Browse all research